Cargando…

Improvement of skin conditions by ingestion of Aspergillus kawachii (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial

PURPOSE: The present study examined the effect of ingestion of Koji extract containing 14-dehydroergosterol (14-DHE), prepared from Aspergillus kawachii NBRC4308, on improvement of skin conditions among healthy volunteers. SUBJECTS AND METHODS: In a randomized, double-blind, placebo-controlled, para...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugihara, Yoshihiko, Ikushima, Shigehito, Miyake, Mika, Kirisako, Takayoshi, Yada, Yukihiro, Fujiwara, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849931/
https://www.ncbi.nlm.nih.gov/pubmed/29563825
http://dx.doi.org/10.2147/CCID.S152979
_version_ 1783306137190268928
author Sugihara, Yoshihiko
Ikushima, Shigehito
Miyake, Mika
Kirisako, Takayoshi
Yada, Yukihiro
Fujiwara, Daisuke
author_facet Sugihara, Yoshihiko
Ikushima, Shigehito
Miyake, Mika
Kirisako, Takayoshi
Yada, Yukihiro
Fujiwara, Daisuke
author_sort Sugihara, Yoshihiko
collection PubMed
description PURPOSE: The present study examined the effect of ingestion of Koji extract containing 14-dehydroergosterol (14-DHE), prepared from Aspergillus kawachii NBRC4308, on improvement of skin conditions among healthy volunteers. SUBJECTS AND METHODS: In a randomized, double-blind, placebo-controlled, parallel-group study, 70 healthy adult women who felt that their skin was dry ingested either a placebo dietary supplement or Koji extract (200 mg/day) supplement containing 0.1% 14-DHE for 12 weeks. Throughout the treatment period and for 4 weeks afterward, objective indicators – including moisture content of the stratum corneum, trans-epidermal water loss (TEWL), and skin wrinkles – were evaluated; in addition, the subjects answered a questionnaire on their skin conditions with ratings on a visual analog scale. Statistical analysis was conducted on the basis of differences from baseline scores. RESULTS: Compared with the placebo group, the Koji extract group showed significantly increased forearm moisture at 4, 8, and 16 weeks (p < 0.05 on unpaired t-test). The questionnaire survey showed a marked improvement in skin conditions, particularly crow’s feet, in the Koji extract group versus the placebo group at 8 weeks (p < 0.05 by unpaired t-test). Furthermore, the Koji extract group showed a trend (p < 0.10) toward improvement in skin moisture (at 4 weeks), dryness around the eyes/mouth (at 4 weeks), and overall skin condition (at 8 weeks) versus the placebo group. CONCLUSION: Ingestion of Koji extract containing 14-DHE was demonstrated to have positive effects toward improving skin conditions – in particular, on increasing skin moisture in the stratum corneum.
format Online
Article
Text
id pubmed-5849931
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58499312018-03-21 Improvement of skin conditions by ingestion of Aspergillus kawachii (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial Sugihara, Yoshihiko Ikushima, Shigehito Miyake, Mika Kirisako, Takayoshi Yada, Yukihiro Fujiwara, Daisuke Clin Cosmet Investig Dermatol Original Research PURPOSE: The present study examined the effect of ingestion of Koji extract containing 14-dehydroergosterol (14-DHE), prepared from Aspergillus kawachii NBRC4308, on improvement of skin conditions among healthy volunteers. SUBJECTS AND METHODS: In a randomized, double-blind, placebo-controlled, parallel-group study, 70 healthy adult women who felt that their skin was dry ingested either a placebo dietary supplement or Koji extract (200 mg/day) supplement containing 0.1% 14-DHE for 12 weeks. Throughout the treatment period and for 4 weeks afterward, objective indicators – including moisture content of the stratum corneum, trans-epidermal water loss (TEWL), and skin wrinkles – were evaluated; in addition, the subjects answered a questionnaire on their skin conditions with ratings on a visual analog scale. Statistical analysis was conducted on the basis of differences from baseline scores. RESULTS: Compared with the placebo group, the Koji extract group showed significantly increased forearm moisture at 4, 8, and 16 weeks (p < 0.05 on unpaired t-test). The questionnaire survey showed a marked improvement in skin conditions, particularly crow’s feet, in the Koji extract group versus the placebo group at 8 weeks (p < 0.05 by unpaired t-test). Furthermore, the Koji extract group showed a trend (p < 0.10) toward improvement in skin moisture (at 4 weeks), dryness around the eyes/mouth (at 4 weeks), and overall skin condition (at 8 weeks) versus the placebo group. CONCLUSION: Ingestion of Koji extract containing 14-DHE was demonstrated to have positive effects toward improving skin conditions – in particular, on increasing skin moisture in the stratum corneum. Dove Medical Press 2018-03-09 /pmc/articles/PMC5849931/ /pubmed/29563825 http://dx.doi.org/10.2147/CCID.S152979 Text en © 2018 Sugihara et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Sugihara, Yoshihiko
Ikushima, Shigehito
Miyake, Mika
Kirisako, Takayoshi
Yada, Yukihiro
Fujiwara, Daisuke
Improvement of skin conditions by ingestion of Aspergillus kawachii (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial
title Improvement of skin conditions by ingestion of Aspergillus kawachii (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial
title_full Improvement of skin conditions by ingestion of Aspergillus kawachii (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial
title_fullStr Improvement of skin conditions by ingestion of Aspergillus kawachii (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial
title_full_unstemmed Improvement of skin conditions by ingestion of Aspergillus kawachii (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial
title_short Improvement of skin conditions by ingestion of Aspergillus kawachii (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial
title_sort improvement of skin conditions by ingestion of aspergillus kawachii (koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849931/
https://www.ncbi.nlm.nih.gov/pubmed/29563825
http://dx.doi.org/10.2147/CCID.S152979
work_keys_str_mv AT sugiharayoshihiko improvementofskinconditionsbyingestionofaspergilluskawachiikojiextractcontaining14dehydroergosterolinarandomizeddoubleblindcontrolledtrial
AT ikushimashigehito improvementofskinconditionsbyingestionofaspergilluskawachiikojiextractcontaining14dehydroergosterolinarandomizeddoubleblindcontrolledtrial
AT miyakemika improvementofskinconditionsbyingestionofaspergilluskawachiikojiextractcontaining14dehydroergosterolinarandomizeddoubleblindcontrolledtrial
AT kirisakotakayoshi improvementofskinconditionsbyingestionofaspergilluskawachiikojiextractcontaining14dehydroergosterolinarandomizeddoubleblindcontrolledtrial
AT yadayukihiro improvementofskinconditionsbyingestionofaspergilluskawachiikojiextractcontaining14dehydroergosterolinarandomizeddoubleblindcontrolledtrial
AT fujiwaradaisuke improvementofskinconditionsbyingestionofaspergilluskawachiikojiextractcontaining14dehydroergosterolinarandomizeddoubleblindcontrolledtrial